![]() Karuna Therapeutics Karuna Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing novel therapies to address disabling neuropsychiatric conditions. | |||
Founding Date | Founding Date 2017 | Founding Date 2009 | Founding Date N/A |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Utrecht, NL HQ Amsterdam, NL | Locations Boston, US HQ Boston, US Carmel, US | Locations HQ |
Employees | Employees 150% decrease | Employees 1919% increase | Employees N/A |
Valuation ($) | Valuation ($) N/A | Valuation ($) 12.6 b | Valuation ($) 191.5 k |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $654k (FY, 2023) | Revenue (est.) N/A |
Net income | Net income N/A | Net income ($433.7m) (FY, 2023) | Net income ($9k) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 730k | Total funding raised $ 118.7m | Total funding raised N/A |

Karuna Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing novel therapies to address disabling neuropsychiatric conditions.
View company